Fisher & Paykel Healthcare Corporation Limited
FPH
Classement en actions
#1344
Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes... Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes in the development, manufacturing, and marketing of a wide array of medical device products and systems. These solutions are primarily utilized for acute and chronic respiratory care, during surgical procedures, and in the treatment of obstructive sleep apnea (OSA) within both hospital and home environments. Key offerings include the Airvo 2, a humidified nasal high flow system; Optiflow, for nasal high flow therapy; and the F&P 850 System, which facilitates noninvasive and invasive ventilation. The company also provides a comprehensive range of infant respiratory products, encompassing devices for resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Its extensive hospital product portfolio features humidification equipment, breathing circuits, chambers, various masks, nasal cannulas, surgical components, and different interfaces and accessories. For homecare, Fisher & Paykel Healthcare supplies masks, CPAP devices, data management software, humidifiers, and related accessories. Established in 1934, the company is headquartered in Auckland, New Zealand.
Prix de l'action
$28.18
Capitalisation boursière
$16.55B
Changement (1 jour)
-4.74%
Changement (1 an)
37.27%
Pays
NZ
Échange Fisher & Paykel Healthcare Corporation Limited (FPH)
Catégorie
Healthcare
Bénéfices pour Fisher & Paykel Healthcare Corporation Limited (FPH)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Fisher & Paykel Healthcare Corporation Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Fisher & Paykel Healthcare Corporation Limited de 2026 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $3.81B | - |
US
|
|
| $4.11B | - |
FR
|
|
| - | - |
JP
|
|
| $1.59B | - |
US
|
|
| - | - |
CH
|
